Article
[Molecular mechanisms involved in hormone resistance of prostate cancer].
Bulletin du cancer - 1 Oct 2004
Cabrespine Aurélie, Guy Laurent, Chollet Philippe, Debiton Eric, Bay Jacques-Olivier
Abstract excerpt
Prostate cancer has an androgen-dependent growth mediated by the androgen receptor (AR). Androgen pathway blockage is the standard therapy for the treatment of prostate cancers at an advanced stage. In spite of an initial sensitivity, prostate cancers become more or less quickly towards androgen-independent. Hormone refractory can be due to amplification of AR gene, AR mutations and the increase in co-activator...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
